Cyclacel Pharmaceuticals
CYCC
CYCC
2 hedge funds and large institutions have $8.44M invested in Cyclacel Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$202K
Puts
–
Net Calls
+$202K
Net Calls Change
+$2.11M
Top Buyers
No buyers this quarter
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
AllianceBernstein
Nashville,
Tennessee
| $1K | -$1K | – | – |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $3 | -$3 | – | – |
|
|
TC
28
TFS Capital
West Chester,
Pennsylvania
| – | -$416K | – | – |
|
|
CCA
29
Catalyst Capital Advisors
Huntington,
New York
| – | -$632K | – | – |
|
|
PCM
30
Prelude Capital Management
New York
| – | -$6K | – | – |
|
31
Nomura Holdings
Tokyo,
Japan
| – | -$136K | – | – |
|
32
Wells Fargo
San Francisco,
California
| – | -$20K | – | – |
|
|
ARTA
33
A.R.T. Advisors
New York
| – | -$149K | – | – |
|